Xiaofeng Li
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Vectors
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 7
- Viral gastroenteritis research and epidemiology 7
- Viral Infections and Vectors 4
- SARS-CoV-2 detection and testing 3
-
- Gut microbiota and health 4
- Co-authors
- Cheng‐Feng Qin (20 shared papers)Siwen Huang (5 shared papers)Zhixiang Yan (6 shared papers)Yong‐Qiang Deng (14 shared papers)Zhenyi Zhang (4 shared papers)Hong Shan (3 shared papers)Lin Lü (5 shared papers)Renxu Lai (3 shared papers)
- Journals
- PLoS ONE (2 papers)Cell Discovery (2 papers)Frontiers in Public Health (2 papers)Journal of Fungi (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaofeng Li
82 papers receiving 2.1k citations
Xiaofeng Li's Hit Papers
Peers
Comparison fields: 5 of 135
- Infectious Diseases 788
- Neurology 232
- Parasitology 108
- Gastroenterology 55
- Biological Psychiatry 25
Countries citing papers authored by Xiaofeng Li
This map shows the geographic impact of Xiaofeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Li more than expected).
Fields of papers citing papers by Xiaofeng Li
This network shows the impact of papers produced by Xiaofeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Li. The network helps show where Xiaofeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection Hit paper breakdown → | 2020 | 646 |
| 2 | 2016 | 202 | |
| 3 | 2015 | 109 | |
| 4 | 2015 | 93 | |
| 5 | 2016 | 81 | |
| 6 | 2017 | 77 | |
| 7 | 2012 | 60 | |
| 8 | 2021 | 51 | |
| 9 | 2015 | 46 | |
| 10 | 2007 | 45 | |
| 11 | 2017 | 42 | |
| 12 | 2024 | 41 | |
| 13 | 2021 | 35 | |
| 14 | 2021 | 33 | |
| 15 | 2017 | 32 | |
| 16 | 2022 | 31 | |
| 17 | Ban-Lan-Gen Granule Alleviates Dextran Sulfate Sodium-Induced Chronic Relapsing Colitis in Mice via Regulating Gut Microbiota and Restoring Gut SCFA Derived-GLP-1 Production | 2022 | 30 |
| 18 | 2013 | 26 | |
| 19 | 2009 | 24 | |
| 20 | 2017 | 24 |
About Xiaofeng Li
Xiaofeng Li is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Genetics and Immunology, having authored 87 papers that have together received 2.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (7 papers), Viral gastroenteritis research and epidemiology (7 papers), Gut microbiota and health (4 papers), Viral Infections and Vectors (4 papers), Animal Virus Infections Studies (3 papers), Influenza Virus Research Studies (3 papers) and SARS-CoV-2 detection and testing (3 papers). The work is most often cited by research in Infectious Diseases (788 citations), Neurology (232 citations), Parasitology (108 citations), Gastroenterology (55 citations) and Biological Psychiatry (25 citations). Xiaofeng Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Cheng‐Feng Qin, Siwen Huang, Zhixiang Yan, Yong‐Qiang Deng, Zhenyi Zhang, Hong Shan, Lin Lü, Renxu Lai, Zhaoxiong Fang and Honggang Shi. Their work appears in journals such as PLoS ONE, Cell Discovery, Frontiers in Public Health, Journal of Fungi and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.